Author

Haokang Feng

Institutions: Shanghai Medical College of Fudan University, Fudan University, Zhongshan Hospital

Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Zhongshan Hospital

OpenAlex ID: A5113091997

The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy

2024 · Haokang Feng, Jiale Feng, et al. · Cancers · 24

Metagenomic Microbial Signatures for Noninvasive Detection of Pancreatic Cancer

2025 · Yueying Chen, Fulin Nian, et al. · Biomedicines · 10

Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literature review

2025 · Yuquan Guo, Siyang Han, et al. · HepatoBiliary Surgery and Nutrition · 6

SGMS2+ macrophages enhance NR4A3hi NK cell infiltration to improve prognosis and PD-1 treatment efficacy in hepatocellular carcinoma

2025 · Fansheng Meng, Fulin Nian, et al. · Journal of Translational Medicine · 4

Targeting annexin A2 enhances anti-PD-1 immunotherapy in pancreatic ductal adenocarcinoma by remodeling the tumor immune microenvironment

2025 · Mengmeng Liu, Ganggang Wang, et al. · International Immunopharmacology · 3

Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma

2025 · Yue Wang, Pengxiang Wang, et al. · Discover Oncology · 2

Tumor‐Infiltrating mregDCs Restrain Anti‐Tumor Immunity in Early Relapse HCC

2026 · Zefan Zhang, Lin Ding, et al. · Advanced Science

Unveiling circulating targets in pancreatic cancer: Insights from proteogenomic evidence and clinical cohorts

2025 · Haokang Feng, Zhixue Chen, et al. · iScience

Works count: 8

Citation count: 49

H-index: 4

I10-index: 2